Brian Goff
Chief Executive Officer, Director · AGIOS PHARMACEUTICALS, INC.
- 2025
- Jun 23, 2026
- 5
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Brian Goff files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Sarah Gheuens - $1.55M in AGIO purchases and sales in the last 12 months
- John M. Leonard - $1.44M in NTLA purchases and sales in the last 12 months
- Fred E. Cohen - $1.40M in NTLA purchases and sales in the last 12 months
- James William Burns - $265K in AGIO purchases and sales in the last 12 months
- Cecilia Jones - $255K in AGIO purchases and sales in the last 12 months
- Edward J. Dulac III - $234K in NTLA purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Brian Goff?
Brian Goff is a corporate insider, tracked as Chief Executive Officer, Director of AGIOS PHARMACEUTICALS, INC. (AGIO). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Brian Goff last file a Form 4?
The most recent primary Form 4 on record is dated 23 June 2026, one of 5 filings going back to 2025.
Has Brian Goff been buying or selling stock?
Recorded transactions: 0 open-market purchases and 6 open-market sales ($1.59M) across all tracked filings.
